Loading

Annals of Food Processing and Preservation

Isolation and Characterization of Wild Yeast Strains Producing Beta Glucans; Probiotic Systemic Effect in Mice under Conditions of Environmental Stress

Research Article | Open Access | Volume 3 | Issue 1

  • 1. Department of Biology, Higher Technological Institute of Irapuato, Mexico
  • 2. Laboratory of Applied Biotechnology, Mexico
  • 3. Department of Biochemistry, Technological Institute of Piety, Mexico
+ Show More - Show Less
Corresponding Authors
Gustavo A. de la Riva, Department of Biochemistry, Technological Institute of Piety, Mexico
ABSTRACT

Probiotics are living microorganism intended to confer health benefits to the host organism. Some of them produce and retain group of metabolites helping the good conditions of organism, some of the effects of probiotics are mediated by metabolites that promote good health by improving the host´s immune response and antioxidant capacity. β-glucans are glucose-polymer present in yeast, fungi, and plants that can stimulate cellular immunological response and reduce oxidative stress damages in both, vertebrate and invertebrate species. In this study, we isolated and characterized wild yeast strains from different regions of Mexico. About 250 different isolates were obtained from fermented fruit extracts, of which 44 were selected and further characterized microbiologically, biochemically and molecularly. Restriction fragment length polymorphism of PCR-amplified internal transcribed spacer (ITS) region revealed a wide diversity among selected isolates, and this was confirmed by DNA sequencing. Biochemically, diversity was supported by a wide range of β-glucans levels produced under laboratory conditions. Two identified species, Saccharomyces cerevisiae and Debaryomyces hansenii show the most promising β-glucans profiles and were subjected to a kinetic study over 24 hours. The highest β-glucans levels were obtained in stationary phase of growth. Both strains were evaluated as a probiotic. Evaluation as probiotics in mice under environmental stress conditions showed that animals receiving yeast strain as a dietary supplement regained weight more rapidly and had better liver, renal and immunological functions compared to a control group fed with a normal diet. β-glucans also proved to be effective in reducing oxidative stress damage and protecting renal, hepatic and immunological functions in support of systemic positive effect.

KEYWORDS

•    Probiotic
•    Yeast
•    β-glucans
•    Oxidative stress
•    Immune response

CITATION

de Jesus Torres-Osorno A, López-Mendoza FJ, de la Riva GA (2018) Isolation and Characterization of Wild Yeast Strains Producing Beta Glucans; Probiotic Systemic Effect in Mice under Conditions of Environmental Stress. Ann Food Process Preserv 3(1): 1023.

INTRODUCTION

Yeasts are eukaryotic microorganisms commonly found in the environment, and often isolated from sugar-rich substrates undergoing fermentation [1,2]. Examples include naturally occurring strains on the skin of fruits and berries such as grapes, apples and peaches, and plant exudates such as plant saps or cacti. Some yeasts are found in association with soil and insects [1,2]. As chemo organotrophic organisms, yeasts use organic compounds as a source of energy and do not require sunlight to grow. Carbon is obtained mostly from hexose sugars, such as glucose and fructose, or disaccharides such as sucrose and maltose. Some species can metabolize pentose sugars such as ribose alcohols, and organic acids [3]. Yeast species either require oxygen for aerobic cellular respiration (obligate aerobes) or are anaerobic, with some anaerobes capable of using aerobic methods of energy production (facultative anaerobes) [3]. Yeasts grow better in a neutral or slightly acidic pH environment. The ecological function and biodiversity of yeasts are relatively unknown compared to those of other microorganisms [4].

Probiotics are live microorganisms that confer health benefits to the host when administrated in adequate amounts [1, 2]. The use of probiotics is based on the role of these microorganisms as possible modulators of the intestinal microbiota and the immune system [5]. Probiotics have a wide spectrum of immunomodulatory effects as they are capable of acting on innate and acquired immunity, protecting the host against infections and promoting more optimal organic response to environmental conditions that induce oxidative stress processes [6,7].

Yeasts are particularly interesting microorganisms due to their diversity, versatility and wide practical uses. Yeasts are widely accepted as an important component of human food and animal feed. Yeasts are a subject of permanent research, and they display important properties that are used in the production of certain compounds, enzymes and toxins [7]. Among these compounds are β-glucans, glucose homopolysaccharides with variable degrees of branching that are linked through β-(1 → 3) and β-(1 → 4) bonds. Evidence from in vitro and in vivo studies suggests that β-glucans can be used as prebiotics thanks to their ability to promote the growth of beneficial microorganisms such as Lacto bacillus ssp. and Bifido bacterium ssp. in the gut microbiota of mammals, including humans [8]. Another property, mainly attributed to β-glucans, is the modulation of the immune system [9].

In the present work, we isolated native yeast strains from different fruit extracts collected from different regions of Mexico. A total of 250 isolates were obtained of which, 44 were selected for further microbiological, biochemical and molecular characterization. One of selected yeasts was tested in mice under environmental stress conditions. The results of this study support positive systemic effect of dietary supplementation with selected strain of Saccharomyces cerevisiae and the positive use of this strain as probiotics in animals and humans. Probiotic supplementation could have a dramatic impact on livestock productivity by preventing weight loss, improving gastrointestinal health, boosting the immunological response to common pathogens and promoting more optimal organic response to environmental conditions.

MATERIALS AND METHODS

Culture media

The Martins Rose Bengal Agar medium (glucose 10 g/L, peptone 5 g/L, K2 HPO4 0.5 g/L, KH2 PO4 0.5 g/L, MgSO4 .7H2 O 0.5 g/L, Rose Bengal 30 mg/L, agar 15 g /L, yeast extract 0.5 g/L and streptomycin sulfate 30 mg/l), was used for the isolation of native yeast strains and supplemented with either glucose (MRAG) or xylose (MRAX) as carbon source. YPG (yeast extract 10 g/L, peptone 10 g/L, glucose 20 g/L and YPX (yeast extract 10 g/L, peptone 10 g/L, xylose 20 g/L) media were testing β-glucans production in the 44 selected strains. For solid media microbiological agar was added at 15g/L.

Strain isolation

Native yeast strains were isolated from guava, orange, mango, papaya, apple, lemon, cucumber, banana and pineapple ordered from different Mexican regions with disparate climatic and soil conditions. An integral crude extract was obtained from 10g of each fruit sample by maceration followed by addition of 25 mL of sterile distilled water and. The extract was transferred to a 250mL Erlenmeyer flask and incubated for 5 days at 30°C with moderate agitation (100 rpm / min). At the end of this period, the pH of fermented fruit cultures was measured. One milliliter of fermented extract from each culture were serially diluted up to 105 and were spread on selective medium MRA or MRA-X medium supplemented with streptomycin at 30 mg/ L at 30°C for 48 hours.

Colony morphology

Individual yeast colonies were streaked from fresh MRAG or MRAX plates and grown at 30°C for 48 hours to study colony morphology according to the following criteria: 1) size at the time of incubation diameter in mm from a fractions of mm up to 10 mm; 2) form (punctate, irregular, circular, rhizoid, fusiform); 3) elevation (flat, monticular, elevated, umbelliform, convex, umbilicated); 4) border or contour (whole, wavy, lobate, serrated, filamentous or curly); 5) color (white, yellow, black, brown, orange, etc.); 6) surface (smooth or rough); 7) appearance (moist, dry, cottony, powdery, velvety, hairy, grainy); 8) Consistency (soft or butyrous, viscose, membranous or hard); 9) reflected light (bright or matte); and 10) transmitted light (translucent or transparent).

Total DNA extraction

Total DNA was extracted from each strain using the method of Hoffman and Winston [10]. Briefly, 5 mL of MRAG or MRAX liquid medium in 15 mL Falcon tubes were inoculated and grown at 30ºC and 110 rpm/mL for 48 hours. Cells were collected by centrifugation (5minutes at 3500 rpm), washed one time with 500 μL of sterile water, and resuspended with the mixture (200 μL of Winston solution, 200 μL of Tris-saturated phenol/chloroform and glass), this mixture were vortexes at full speed for 5 minutes, then 200 μL TE (10mM Tris, 1mM EDTA) was added and centrifuged for 1 minute at 10000 rpm. DNA was precipitated by adding 1 mL of absolute ethanol to the supernatants, followed by inverting 6 to 10 times and centrifuge at full speed for 5 minutes. DNA pellets were washed with 500 µL of ethanol 70%, allowed to air dry for 15 minutes and dissolved in 50 μL of sterile water.

PC ramplification of the ITS regions

The 5.8S rDNA internal transcribed spacer (ITS) regions were amplified by polymerase chain reaction (PCR) using the primers ITS1 (5’-TCCGTAGGTGAACCTGCGG-3’) and ITS4 (5’-TCCTCCGCTTATTGATATGC-3’). PCR reactions were prepared in a total volume of 25 μL containing 1 μL of total DNA, 12.5 μL of Master Mix (Thermo Fisher Scientific, Massachusetts, USA), 9.5 μl of water, 1 μL (Cf:10 μM) oligonucleotide ITS1 and 1 μL (Cf: 10 μM) of ITS4oligonucleotide. Amplification was performed in a thermocycler (Labnet, New Jersey, USA) under the following conditions: denaturation 94ºC for 5 min, 35 cycles of amplification (94ºC for 1 min, 52ºC for 2 min, 72ºC for 2 min), and termination stage: 72ºC for 10 min. The PCR products were visualized on a 1% agarose gel, using E-gel Imager (Thermo Fisher Scientific, Massachusetts, USA) with blue light base [11]. The length of ITS sequences ranged from 600 to 750 bp.

RFLP of amplified ITS regions

Restriction fragment length polymorphism (RFLP) analysis of the PCR-amplified ITS regions was performed using the method of Granchi., [12]. Briefly, 20 μL of the PCR products were drop onto 0.025 µm VSWP membranes (Millipore, Sigma, USA) left to be dialyzed onto sterile water for 30 minutes. Dialyzed PCR products were recovered [9], and digested with Hha I, Hae III and Hinf I [12], according to supplier´s instructions (Thermo Fisher Scientific, USA). The digestions were visualized on 2% TAE agarose by electrophoresis. PCR products were also sequenced and selected yeast strains were identified by BLAST [11-13].

β-glucan determination

Levels of 1,3:1,6-β-glucan were measured using β-glucan Assay Kit (K-YBGL β-glucan Assay Kit, MegazymeTM, Ireland) according to the manufacturer´s instruction as previously reported elsewhere [14]. The β-glucan levels were determined in preliminary massive test and then in kinetic test to establish the optimal growth phase for β-glucan production in the selected high producing yeasts.

Cell adhesion assay

Mouse intestinal epithelial cells were obtained from our institutional cell & culture biobank and maintained in Eagle’s minimal essential medium (MEM) supplemented with glutamine (0.584 g/L),sodium bicarbonate (3.7 g/L), antibiotics (penicillin 100 μg/ml, streptomycin 100 μg/mL, spectinomycin100 μg/mL) and 5% bovine fetal serum (FBS) at pH 7.2. T75 Culture flasks were maintained in atmosphere of 5% CO2 at 37°C [15]. For the assay, cell monolayers of β-glucans high producer strains were washed three times with prewarmed MEM medium without FBS serum, fixed with cold methanol, stained with Giemsa stain. Cells were analyzed under the microscope and adherence score calculated. Strains with the highest score selected for further tests.

Animal care, husbandry and probiotic testing

Mouse experiments were performed in accordance with the Guidelines for Ethical Conduct in the Care and Use of Nonhuman Animals in Research and the Institutional Committee of Ethics, Animal Care and Welfare [16]. Six-week-old BALB/c mice were housed in temperature controlled (22-25ºC) on a 12h light/dark cycle (12h/12h) with access to water and food ad libitium. The normal diet consists in NUTRICUBOS, provided from Lab Chows (https://www.nutrimentospurina.com). A total of 20 mice were divided into 4 groups of 5 mice each, two groups were fed with normal control diet, and the other two groups were fed with NUTRICUBOS enriched with 20% w/w of one of the selected yeast strains. For each experimental diet, one of the two groups, were subjected to oxidative stress. Oxidative stress was induced by perturbing living conditions in a number of ways: change of room, food deprivation, diminishing of water supply and alteration of the acoustics for three days (at days 11, 12, 13 of diet exposure). At the end of the test the animals were transferred to another facility and the normal living conditions were restored. The animals were weighed daily until day 30th .

Blood biochemical analysis

Murine blood samples were collected through the ophthalmic plexus using a glass Pasteur pipette at the day 0 (prior to day exposure) and at the day 10th, 13th and 30th of experiment. Samples were centrifuged at 1831 x g for plasma collection. Liver and renal functions were evaluated by measuring of 11 biochemical markers (glucose, total protein, serum albumin, urea, uric acid, creatinine, alanine transaminase, aspartate transaminase, alkaline phosphatase, and serum glutathione peroxidase and serum total antioxidant capacity). Measurements were done using commercial kits according to the manufacturers’: a)glucose (Mouse Glucose Assay Kit, Crystal Chem., Elk Grove Village, IL, USA); b) total protein (Total Protein Assay Kit, Bio Scientific Corporation, Austin, TX, USA); c) Serum Albumin (Quanti Chrom™ BCG Albumin Assay Kit, Bio Assay Systems, Hayward, CA,USA); d) Urea BUN (Mouse Blood Urea Nitrogen ELISA Kit, Creative Diagnostics, Shirley, NY, USA); e) Uric Acid (Quanti Chrom™ Uric Acid Assay Kit, Bio Assay Systems, Hayward, CA, USA); f) Creatinine (Mouse Creatinine CREA ELISA, Kamiya Biomedical Co., Seattle, WA, USA); g) Alanine Transaminase (EnzyChrom™ Alanine Transaminase Assay Kit, Bio Assay Systems, Hayward, CA, USA); h) Aspartate Transaminase (EnzyChrom™ Aspartate Transaminase Assay Kit, Bio Assay Systems, Hayward, CA, USA);i)Alkaline phosphatase (Mouse Alkaline Phosphatase (ALP) ELISA, Kamiya Biomedical Co., Seattle, WA, US); j) Serum GSH-Activity (Mouse Glutathione (GSH) Colorimetric Cuvette Detection Kit (Innovative Research, MI, USA) and k) Plasma Total Antioxidant Capacity (Total Antioxidant Capacity Assay Kit, ABCAM, Cambridge, MA, USA).

Mouse immunological status

The immunological status of animals were evaluated by the determining of lymphocytes, neutrophils, monocytes, eosinophils and basophils during diet-exposure experiment using hemocytometer [17].

Statistical analysis

Data were analyzed using one-way ANOVA followed by Dunnett’sor Fisher’s protected least significant difference multiple comparison testing in SPSS13.0 (SPSS, Chicago, IL, USA). When necessary, data were transformed for normalization and to reduce heterogeneity of variance, p-values less than 0.05 were statistically considered significant.

RESULTS AND DISCUSSION

Isolation and characterization of wild yeast strains

Approximately 1500 yeast species described so far about a dozen are used at industrial scale and some 70-80 species have been shown to possess potential value for biotechnology [18]. It has been suggested that known yeast species represent roughly 5% of the total number that may exist in the nature [18]. The current applications of yeasts have been greatly expanded beyond classical applications over the past decades. Yeasts are also recognized as probiotics. Yeast cell wall contains β-glucans that can function as antioxidant by preventing damages caused by oxidative stress. Oxidative stress results in several altered metabolic and inflammatory conditions and has been center of extensive research in both human and veterinary medicine [19- 21].

In this study we isolated native yeast strains from fruit extracts collected across Mexico as a part of biorepository project. A total of 256 strains were isolated, 187 in MRA containing glucose as carbon source and 69 in MRA containing xylose. The fruit type and region of origin, the final pH generated during fermentation and the carbon source used during isolation were important factors contributing to the diversity of the yeast collection. In addition to sugars, many fruits also contain acids such as citric acid and other metabolites. Thus yeasts have evolved to survive in a slightly acid condition and consequently fermentation performs best in the pH ranging 4.5 to 5.5. We analyzed fruit extracts with acid (pH 3 to 5), neutral (pH 6 to 7) and alkaline (pH 8 to 9) pH values. Acid and alkaline media are stressing conditions and yeast isolated from those conditions can be used in similar environments, that are the case of Debaryomyces hansenii that have been used as a probiotic on the immune and antioxidant systems of juvenile leopard grouper Mycteroperca rosacea exposed to stress [22]. Yeast culture on media containing xylose allowed us to isolate wild xylose-metabolizing strains, suitable for the biotransformation of hemicellulose to produce alcohol [23] or xylitol [24].

After analysis of colony morphology in isolated strains we selected 44for further microbiological and molecular analysis. Initially, we performed RFLP analysis of ITS regions by the method of Granchi et al., [12] but we were unable to identified individual isolates. Because of limitations of conventional and ITS-RFLP methods alone we decided to use DNA sequencing and sequence comparison of the 5.8S rRNA gene and ITS1-ITS4 regions [13], for accurate identification of the yeast strain. We used a combination of Heras-Vázquez et al. [25], and Doniger et al. [26], methodologies. A high degree of diversity among selected strains was evidenced by RFLP analysis of PCR-amplified ITS Zygosaccharomyces ssp., Yarrowia ssp., Rodotorula ssp. and Piscia ssp. Native yeast population has been studied by other authors, demonstrating the existing great diversity of yeasts in different environments and substrates [27-34].The Mexican regions where fruit were collected from have different climatic and soil conditions increased our chances to obtain a greater biodiversity in obtained yeast collection (Table 1).

Table 1: Characterization of yeast strains selected based on colony morphological analysis. Restriction analysis of the 600-750 pb ITS amplicon with Hha I, Hae III and Hinf I resulted in 36 polymorphic groups. Double bands are indicated with a 2 in parenthesis. Classification of yeast isolates based on ITS sequencing and BLAST search is also shown.

Strain Nº

Fruit of Origin

 

Final

pH

Carbon Source

Restriction Length Polymorphism Fragment (bp)

Classification by ITS sequencing

and blast reaching

Hha I

Hae III

Hinf I

RFLP Group

1

Mango

 

4

Xylose

300 (2)

480 (2)

320 (2)

1

Debaryomyces hansenii.

2

Mango

 

4

Xylose

100 (2), 200 (2)

550

320, 350

2

Debaryomyces hansenii.

3

Mango

 

4

Glucose

300 (2)

750

450, 300

3

Saccharomyces cerevisiae

4

Mango

 

4

Glucose

300 (2)

350 (2)

340, 250 (2)

4

Zygosaccharomyces ssp.

5

Mango

 

4

Glucose

350 (2)

500

250, 300

5

Saccharomyces cerevisiae

6

Mango

 

4

Glucose

700

500

250, 350

6

Zygosaccharomyces ssp.

7

Guava

 

5

Glucose

700

500, 100 (2)

350, 380

7

Saccharomyces cerevisiae

8

Guava

 

5

Glucose

300, 230 (2)

800

400 (2)

8

Saccharomyces cerevisiae

9

Guava

 

5

Xylose

300, 250 (2)

800

400, 350

9

Candida intermedia

10

Guava

 

5

Xylose

150 (2), 200 (2)

500, 100 (2)

450, 380

10

Candida intermedia

11

Guava

 

5

Xylose

150 (2), 200

550, 100 (2)

400, 350

11

Pichia stipitis

12

Orange

 

3

Glucose

300,170 (2)

700

350, 400

12

Zygosaccharomyces ssp.

13

Orange

 

3

Glucose

200 (2), 100 (2)

500, 100

250, 350

13

Saccharomyces cerevisiae

14

Orange

 

3

Glucose

200 (2), 100 (2)

500, 100

250, 300

13

Saccharomyces cerevisiae

15

Orange

 

3

Glucose

300, 200 (2)

380 (2)

180, 280 (2)

14

Rhodotorula ssp.

16

Apple

 

3

Xylose

300, 200 (2)

700

400, 350

15

Debaryomyces hansenii.

17

Apple

 

3

Xylose

300, 200

650, 100

400, 350

16

Candida intermedia

18

Apple

 

3

Xylose

300, 250 (2)

540

350 (2)

17

Pichia stipitis

19

Apple

 

3

Xylose

300, 200 (2)

700

300, 380

18

Pichia stipitis

20

Apple

 

3

Glucose

300, 250 (2)

700

300, 380

18

Pichia kudriavzevii

21

Apple

 

3

Glucose

300, 250 (2)

750

350, 400

18

Saccharomyces cerevisiae

22

Apple

 

3

Xylose

300, 200 (2)

700, 100

350, 380

19

Debaryomyces hansenii

23

Banana

 

5

Xylose

300, 200 (2)

500, 100 (2)

300, 350

20

Candida intermedia

24

Banana

 

5

Xylose

300, 200 (2)

500, 100 (2)

300, 350

20

Debaryomyces hansenii

25

Banana

 

5

Glucose

350 (2)

500, 100 (2)

300, 350

20

Saccharomyces cerevisiae

26

Banana

 

5

Glucose

350 (2)

450, 100 (2)

300, 350

21

Saccharomyces cerevisiae

27

Papaya

 

8

Xylose

350, 230 (2)

500

300, 350

22

Debaryomyces hansenii

28

Papaya

 

8

Xylose

350 (2)

600

380 (2)

23

Debaryomyces hansenii

29

Cucumber

 

9

Glucose

750

430 (2)

750

24

Pichia kudriavzevii

30

Cucumber

 

9

Glucose

350, 300

350 (2)

700

25

Yarrowia ssp.

31

Cucumber

 

9

Glucose

350, 200 (2)

500

320, 400

26

Pichia kudriavzevii

32

Cucumber

 

9

Glucose

350, 300

350, 450

320,400

27

Yarrowia lipolytica

33

Lemon

 

7

Glucose

350 (2)

500, 350

250, 380

28

Saccharomyces cerevisiae

34

Lemon

 

7

Glucose

350 (2)

430, 250

350, 450

29

Saccharomyces cerevisiae

35

Lemon

 

7

Glucose

350 (2)

350, 500

200 (2), 280

30

Saccharomyces cerevisiae

36

Lemon

 

7

Glucose

380 (2)

480

300, 350

31

Saccharomyces cerevisiae

37

Lemon

 

7

Glucose

350 (2)

380 (2)

390 (2)

32

Candida utilis

38

Lemon

 

7

Xylose

350 (2)

580, 200

450, 300

33

Yarrowia lipolytica

39

Lemon

 

7

Xylose

350 (2)

390 (2)

400 (2)

33

Yarrowia lipolytica

40

Pineapple

 

3

Xylose

370 (2)

480 (2)

400 (2)

33

Debaryomyces hansenii.

41

Pineapple

 

3

Xylose

380 (2)

580

200(2) , 300

34

Pichia kudriavzevii

42

Pineapple

 

3

Xylose

350 (2)

450, 350

350 (2)

35

Pichia kudriavzevii

43

Pineapple

 

3

Glucose

350, 400

500 (2)

350 (2)

36

Saccharomyces cerevisiae

44

Pineapple

 

3

Xylose

350 (2)

300, 350

350 (2)

37

Debaryomyces hansenii

(2) Number of observed DNA fragments with approximately the same length

Biodiversity of yeast, as it occurs with other microorganisms, is evolutionary result of adaptation processes to a variety of climatic and soils conditions in close ecological interrelation among all living communities in every ecosystem [35-41].

β-glucans production and selection of promising yeast strains

β-glucan production was quantified for each of 44 selected yeast strains (Table 2)

Table 2: β-glucan production of selected yeast strains. Shaded lanes correspond to strains with the highest production levels.

No

Strain

Cod

Fruit of Origen

Final pH

Carbon Source

β-glucans (μg/mL)

per 25mg wet weight)

1

Debaryomyceshansenii.

YMX1

Mango

4

Xylose

16,68

2

Debaryomyceshansenii.

YMX2

Mango

4

Xylose

16,46

3

Saccharomyces cerevisiae

YMG3

Mango

4

Glucose

15,68

4

Zygosaccharomyces ssp.

YMG4

Mango

4

Glucose

29,61

5

Saccharomyces cerevisiae

YMG5

Mango

4

Glucose

17,08

6

Zygosaccharomyces ssp.

YMG6

Mango

4

Glucose

17,09

7

Saccharomyces cerevisiae

YGG7

Guava

5

Glucose

17,94

8

Saccharomyces cerevisiae

YGG8

Guava

5

Glucose

16,01

9

Candida intermedia

YGX9

Guava

5

Xylose

16,38

10

Candida intermedia

YGX10

Guava

5

Xylose

17,60

11

Pichia stipitis

YGX11

Guava

5

Xylose

16,63

12

Zygosaccharomyces ssp.

YOG12

Orange

3

Glucose

17,29

13

Saccharomyces cerevisiae

YOG13

Orange

3

Glucose

15,61

14

Saccharomyces cerevisiae

YOG14

Orange

3

Glucose

15,94

15

Rhodotorula ssp.

YOG15

Orange

3

Glucose

16,60

16

Debaryomyces hansenii.

YAX16

Apple

3

Xylose

16,834

17

Candida intermedia

YAX17

Apple

3

Xylose

18,09

18

Pichia stipitis

YAX18

Apple

3

Xylose

16,72

19

Pichia stipitis

YAX19

Apple

3

Xylose

16,35

20

Pichia kudriavzevii

YAG20

Apple

3

Glucose

16,61

21

Saccharomyces cerevisiae

YAG21

Apple

3

Glucose

16,59

22

Debaryomyces hansenii

YAX22

Apple

3

Xylose

32,87

23

Candida intermedia

YBX23

Banana

5

Xylose

16,60

24

Debaryomyceshansenii

YBX24

Banana

5

Xylose

17,61

25

Saccharomyces cerevisiae

YBG25

Banana

5

Glucose

17,63

26

Saccharomyces cerevisiae

YBG26

Banana

5

Glucose

12,77

27

Debaryomyces hansenii

YPX27

Papaya

8

Xylose

40,82

28

Debaryomyces hansenii

YPX28

Papaya

8

Xylose

41,14

29

Pichia kudriavzevii

YCG29

Cucumber

9

Glucose

13,86

30

Yarrowia ssp.

YCG30

Cucumber

9

Glucose

13,56

31

Pichia kudriavzevii

YCG31

Cucumber

9

Glucose

13,99

32

Yarrowialipolytica

YCG32

Cucumber

9

Glucose

13,89

33

Saccharomyces cerevisiae

YLG33

Lemon

7

Glucose

13,47

34

Saccharomyces cerevisiae

YLG34

Lemon

7

Glucose

13,12

35

Saccharomyces cerevisiae

YLG35

Lemon

7

Glucose

14,46

36

Saccharomyces cerevisiae

YLG36

Lemon

7

Glucose

41,77

37

Candida utilis

YLG37

Lemon

7

Glucose

16,82

38

Yarrowialipolytica

YLX38

Lemon

7

Xylose

14,97

39

Yarrowialipolytica

YLX39

Lemon

7

Xylose

13,85

40

Debaryomyces hansenii.

YPX40

Pineapple

3

Xylose

14,35

41

Pichia kudriavzevii

YPX41

Pineapple

3

Xylose

14,18

42

Pichia kudriavzevii

YPX42

Pineapple

3

Xylose

14,10

43

Saccharomyces cerevisiae

YPG43

Pineapple

3

Glucose

40,26

44

Debaryomyce shansenii

YPX44

Pineapple

3

Xylose

49,78

(Figure 1).

Figure 1: Determination of total ?-glucan levels expressed as ?g/ml/25 mg of wet weight. NC: Negative control (no cells). The strains selected to further studies were: Zygosaccharomyces ssp. MMG4, Debaryomyces hansenii YMX22, Debaryomyces hansenii YPX28, Saccharomyces cerevisiae YLG36, Saccharomyces cerevisiae YPG43and Debaryomyces hansenii YPX44

Figure 1: Determination of total β-glucan levels expressed as μg/ml/25 mg of wet weight. NC: Negative control (no cells). The strains selected to further studies were: Zygosaccharomyces ssp. MMG4, Debaryomyces hansenii YMX22, Debaryomyces hansenii YPX28, Saccharomyces cerevisiae YLG36, Saccharomyces cerevisiae YPG43and Debaryomyces hansenii YPX44

Six strains showed the highest β-glucans levels and were selected for further studies: 1. Zygosaccharomyces ssp.YMG4 (from Mango extract, final pH4.0, glucose as carbon source) with β-glucans production of 29.61 μg/mL/per 25mg wet weight; 2. Debaryomyces hansenii YAX22 (from apple extract, final pH 3.0, xylose as carbon source) with a production of 32.87 μg/mL/25 mg wet weight; 3. Debaryomyces hansenii YPX28 (from papaya extract, final pH 8.0, Xylose as a carbon source) with a production of 41.14 μg/mL/25 mg wet weight; 4. Saccharomyces cerevisiae YLG36 (From Lemon extract, final pH 7.0, glucose as a carbon source) with a raised production of 41.77 μg/mL/25 mg wet weight; 5. Saccharomyces cerevisiae YPG43 (from Pineapple extract, final pH3.0, glucose as a carbon source) produced 40.26 μg/mL/25 mg wet weight and 6. Debaryomyces hansenii YPX44 (from Pineapple extract, final pH 3.0, xylose as a carbon source) produced 49.78 μg/mL/25 mg wet weight.

Successful probiotic microorganisms must be able to colonize digestive tract of the host animal by adhering to the intestinal mucosa at least temporarily. In a preliminary experiment, the adhesion capacity of selected high β-glucan producers was evaluated in vitro using mouse intestinal epithelial cells. Saccharomyces cerevisiae LX36 and Debaryomyces hansenii PG43 showed good adherence capacity.

Yeast growth dynamic and β-glucan production

Saccharomyces cerevisiae LX36 and Debaryomyces hansenii PG43 strains were used to optimize the culture conditions for β-glucan production. The highest β-glucan levels were obtained at 28ºC, 130 rpm agitation for 24 hours, at early stationary phase (Figure 2,3).

Figure 2: Growth ?-glucan production by selected strain in YPG or YPX media at 28°C and 130 rpm for 24 hours

Figure 2: Growth β-glucan production by selected strain in YPG or YPX media at 28°C and 130 rpm for 24 hours

Figure 3: Dynamics of ?-glucan production by selected strain in YPG or YPX media at 28°C and 130 rpm for 24 hours.

Figure 3: Dynamics of β-glucan production by selected strain in YPG or YPX media at 28°C and 130 rpm for 24 hours.

Debaryomyces hansenii was selected because his ecological, physiological and genetic characteristics making this organism metabolically versatile [42,43]. D. hansenii an osmo-, halo- and xero-tolerant, yeast, can be found in many food products but also in hyper saline waters, such as the coastal marshes and salt lakes [44]. Some strains can be cultivated in media with up to 25% NaCl [44]. This species is generally nonpathogenic, halophile, osmotolerant and oleaginous microorganism, which make it very attractive platform for basic and applied biotechnological research, including a potential use as probiotics. Debaryomyces hansenii PG43 strain is a high β-glucan producer that encourages its use in aquiculture, particularly in shrimp, mussels and oysters farming [42-44], and experiment in such invertebrate species are in progress because the difficulties in establishing experimental facilities at this moment.

Saccharomyces cerevisiae LX36 was selected to test its probiotic function in mice under induced environmental stress. Saccharomyces cerevisiae is probably the most common microorganism widely exploited in food industry. It is well known that this yeast specie promotes both human and animal health [45-46], and enhances the bioavailability of minerals through hydrolysis of different compounds as phytates, folate biofortification, mycotoxins and xenobiotics detoxification [47- 49]. Many studies promote Saccharomyces cerevisiae strains as probiotics restoring gastrointestinal microbial population balance [49]. The different adhesion capacity observed among different strains is seems to be related with the expression of Flo (Flocculim) adhesion-family genes encoding for protein responsible for cell-cell and cell-surface adherence [50]. Rapid evolution and divergence of Flo genes resulted in great diversity of Flo genes, that are usually transcriptionally silent in laboratory yeast strains, a consequence of nonsense mutation in the transcriptional activator FLO8 [50-53]. Each yeast cell family cells harboring small reservoir of different adhesion-encoding genes. Furthermore, it has been reported that S. cerevisiae is able to enhance the survival and therapeutic potential of the probiotic Lactobacillus rhamnosus [54], which has been used to prevent and treat vaginal infection [55].

Effect of diet supplementation with dry Saccharomyces cerevisiae YLG36 in mice

Dry yeast powder from Saccharomyces cerevisiae LX36 was administrated to mice as a dietary probiotic 10 days before three days period of induced environmental stress. Animals subjected to stressing conditions fed with yeast supplement regained weight more rapidly compared to those animals fed with the control non-supplemented diet (Figure 4).

Figure 4: Effect diet supplementation with 25% dry S. cerevisiae YPG43 (rich in ?-glucans) in 6week-old BALB/c mice. Treatments correspond to: ND-control diet (not stressed), SD-supplemented diet (not stressed), NDS-control diet subjected to stress, and SDS-supplemented diet subjected to stress. The stress period during days 11, 12, 13 consisted in changes in living conditions, food deprivation, change of housing location, and reduced water supply. The best response to induced stress and best weight recovery were observed in the animal group fed the supplemented diet. The blood tests establishing parameters of renal, hepatic and immunological functions were done at days 1, 10, 13 and 30. n= 5 in each experimental group

Figure 4: Effect diet supplementation with 25% dry S. cerevisiae YPG43 (rich in β-glucans) in 6week-old BALB/c mice. Treatments correspond to: ND-control diet (not stressed), SD-supplemented diet (not stressed), NDS-control diet subjected to stress, and SDS-supplemented diet subjected to stress. The stress period during days 11, 12, 13 consisted in changes in living conditions, food deprivation, change of housing location, and reduced water supply. The best response to induced stress and best weight recovery were observed in the animal group fed the supplemented diet. The blood tests establishing parameters of renal, hepatic and immunological functions were done at days 1, 10, 13 and 30. n= 5 in each experimental group

Blood biochemical markers related to liver, renal (Table 3,)

Table 3: Blood biochemical tests performed in peripheral blood of BALB/c mice. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group.

No

Test

Group

1st day

s

10th day

s

13th day

s

30th day

s

Remarks

1

Glucose

g/dL

ND

 

89.11

5.22

90.21

4.52

93.45

5.72

91.08

5.91

Stable normal glucose values

NDS

 

87.23

6.31

91.03

6.57

164.26

4.74

110.35

4.72

Glucose increases at day 13th, incomplete recovery of normal values at day 30th.

SD

 

85.90

4.17

90.42

5.34

92.12

4.52

91.37

4.77

Stable normal glucose values

SDS

 

88.35

3.25

92.03

5.62

128.45

4.51

90.42

4.09

Glucose increases at day 13th, complete recovery of normal values at day 30th.

2

Total Protein

mg/dL

ND

 

5.21

0.51

5.24

0.35

5.22

0.21

5.32

0.09

Stable normal total protein values

NDS

 

5.54

0.47

5.36

0.42

5.31

0.34

5.32

0.12

Total Protein increases at day 13th, incomplete recovery of normal values at day 30th.

SD

 

5.19

0.49

5.09

0.32

5.41

0.24

5.21

0.15

Stable total protein values

SDS

 

5.21

0.56

5.31

0.43

5.29

0.31

5.13

0.13

Total Protein increases at day 13th, complete recovery of normal values at day 30th.

3

Serum Albumin

mg/dl

ND

 

2.72

0.11

2.61

0.01

2,65

0.12

2.67

0.03

Stable normal Serum Albumin values

NDS

 

2.75

0.26

2.67

0.02

3,69

0.13

2.71

0.04

Serum Albumin increases at day 13th, incomplete recovery of normal values at day 30th.

SD

 

2.68

0.16

2.73

0.01

2,62

0.12

2.69

0.03

Stable normal glucose values

SDS

 

2.59

0.25

2.84

0.31

3,09

0.09

2.58

0.01

Serum Albumin increases at day 13th, complete recovery of normal values at day 30th.

4

Urea BUN

mg/dL

ND

 

20.62

1.51

20.41

1.45

21.01

1.32

21.32

1.43

Stable normal Urea values

NDS

 

21.32

1.75

20.58

1.41

59.47

1.29

35.21

1.58

Urea increases at day 13th, incomplete recovery of normal values at day 30th.

SD

 

20.04

1.43

21.04

1.25

20.31

1.67

21.05

1.39

Stable normal Urea values

SDS

 

21.03

1.37

20.91

1.36

31.32

1.54

20.51

1.32

Urea increases at day 13th, complete recovery of normal values at day 30th.

5

Uric Acid

mg/dL

ND

 

0.14

0.02

0.15

0.01

0.16

0.01

0.15

0.01

Stable normal Uric Acid values

NDS

 

0.15

0.01

0.14

0.01

0.35

0.02

0.29

0.01

Uric Acid increases at day 13th, incomplete recovery of normal values at day 30th.

SD

 

0.14

0.01

0.15

0.01

0.15

0.01

0.16

0.02

Stable normal Uric values

SDS

 

0.16

0.02

0.15

0.02

0.23

0.02

0.16

0.01

Uric Acid increases at day 13th, complete recovery of normal values at day 30th.

6

Creatinine

mg/dL

ND

 

0.68

0.03

0.74

0.02

0.72

0.01

0.73

0.02

Stable normal Creatinine values

NDS

 

0,71

0.04

0.72

0.02

0.94

0.03

0.85

0.03

Creatinine increases at day 13th, incomplete recovery of normal values at day 30th.

SD

 

0.73

0.03

0.75

0.03

0.71

0.02

0.73

0.03

Stable normal Creatinine values

SDS

 

0.69

0.02

0.73

0.02

0.85

0.02

0.72

0.02

Creatinine increases at day 13th, complete recovery of normal values at day 30th.

7

Alanine Transaminase

U/dL

ND

 

25.82

1.43

26.41

1.57

26.45

2.74

27.93

2.15

Stable normal ALTP values

NDS

 

26.34

1.34

26.18

2.01

67.72

2.92

37.94

2.26

Activity increase at day 13th, incomplete recovery of normal values at day 30th.

SD

 

27.21

1.72

26.63

2.37

26.64

2.31

28.09

2.45

Stable normal ALT values

SDS

 

26.62

1.05

26.34

1.96

39.96

2.08

27.32

1.76

Activity increases at day 13th, complete recovery of normal values at day 30th.

8

Aspartate Transaminase

U/L

ND

 

64.6

2.05

65.38

1.95

66.41

2.05

67.42

2.58

Stable normal ALP values

NDS

62.31

2.28

64.07

2.38

132.54

1.75

85.25

1.79

Activity increase at day 13th, incomplete recovery of normal values at day 30th.

SD

 

61.45

2.34

65.43

2.09

66..21

1.98

66.73

2.58

Stable normal ALP values

SDS

 

62.05

1.94

64.78

2.81

83.42

2.27

65.72

2.36

Activity increases at day 13th, complete recovery of normal values at day 30th.

9

Alkaline Phosphatase

U/L

ND

 

40.52

2.74

39.32

2.21

40.15

2.05

39.54

2.75

Stable normal ALP values

NDS

 

39.67

2.45

40.07

2.32

142.95

2.15

86.56

1.59

Activity increase at day 13th, incomplete recovery of normal values at day 30th.

SD

 

38.45

2.03

39.86

1.97

38.25

2.35

39.15

2.81

Stable normal ALP values

SDS

 

39.37

2.51

39.78

2.17

69.62

2.43

38.23

2.39

Activity increases at day 13th, complete recovery of normal values at day 30th.

10

Serum Glutathione Peroxidase *(GSH-Px)

nmol/ml

ND

 

29.12

1.45

28.5

1.09

28.18

1.34

29.31

1.81

Stable normal GSH-Px values

NDS

 

27.76

1.62

28.8

1.45

18.54

1.55

19.21

1.48

Activity decrease at day 13th, incomplete recovery of normal values at day 30th.

SD

 

28.21

1.59

27.7

1.38

28.73

1.68

28.89

1.21

Stable normal GSH-Px values

SDS

 

28.32

1.05

27.9

1.32

18.82

1.72

27.67

1.43

Activity decrease at day 13th, complete recovery of normal values at day 30th.

11

Serum Total Antioxidant Capacity

nmol/L

ND

 

0.95

0.05

0.96

0.04

0.92

0.04

0.96

0.05

Stable normal TAC values

NDS

 

0.96

0.04

0.95

0.05

0.75

0.05

0.85

0.05

Activity decrease at day 13th (after stress), incomplete recovery of normal values at day 30th.

SD

 

0.95

0.06

0.97

0.04

0.99

0.06

0.99

0.06

Stable normal TAC values

SDS

 

0.94

0.05

0.97

0.04

0.85

0.04

0.97

0.04

Activity decrease at day 13th, complete recovery of normal values at day 30th.

*GSH nmol of reduced glutathione per ml

Figures 5-7)

Figure 5: Glucose, total protein, serum albumin and urea BUN test results for BALB/c mice. Deviation from normal levels was observed in stressed groups, but values should return to normal after stress conditions disappear. Only animals in the stressed group fed probiotic supplemented diet recovered completely at the end of the experiment. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group.

Figure 5: Glucose, total protein, serum albumin and urea BUN test results for BALB/c mice. Deviation from normal levels was observed in stressed groups, but values should return to normal after stress conditions disappear. Only animals in the stressed group fed probiotic supplemented diet recovered completely at the end of the experiment. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group.

Figure 6: Uric acid, creatinine, alanine transaminase and aspartate transaminase test results for BALB/c mice. Deviation from normal levels was observed in stressed groups, but values should return to normal after stress conditions disappear. Only animals in the stressed group fed probiotic supplemented diet recovered completely at the end of the experiment. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group

Figure 6: Uric acid, creatinine, alanine transaminase and aspartate transaminase test results for BALB/c mice. Deviation from normal levels was observed in stressed groups, but values should return to normal after stress conditions disappear. Only animals in the stressed group fed probiotic supplemented diet recovered completely at the end of the experiment. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group

Figure 7: Alkaline phosphatase, glutathione peroxidase and plasma total antioxidant capacity (TAC) test results for BALB/c mice. Deviation from normal levels was observed in stressed groups, but values should return to normal after stress conditions disappear. Only animals in the stressed group fed probiotic supplemented diet recovered completely at the end of the experiment. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group

Figure 7: Alkaline phosphatase, glutathione peroxidase and plasma total antioxidant capacity (TAC) test results for BALB/c mice. Deviation from normal levels was observed in stressed groups, but values should return to normal after stress conditions disappear. Only animals in the stressed group fed probiotic supplemented diet recovered completely at the end of the experiment. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group

and immunological functions were also evaluated (lymphocytes, neutrophils, monocytes, eosinophils and basophils) (Table 4) 

Table 4: White blood cells counts in BALB/c mice. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group.

No

Test

Group

1st day

10th day

13th day

30th day

Description of tendency

Cells x 103/ µl

s

Cells x 103/µl

s

Cells x 103/µl

s

Cells x 103/µl

s

1

Lymphocytes

ND

 

10.42

0.7

10.09

0.6

10.55

0.7

10.49

0.5

Without significant changes

 

 

NDS

 

10.1

0.5

9.97

0.5

6.45

0.6

8.29

0.5

Decrement at 13th day, Slow recovery

at 30th day

 

 

SD

 

10.37

0.6

11.08

0.7

10.92

0.6

12.55

0.6

Increment

 

 

SDS

 

10.51

0.5

11.64

0.6

13.05

0.7

13.08

0.5

Increment at 10th day

2

Neutrophils

ND

 

5.70

0.42

5.51

0.39

5.67

0.39

5.63

0.41

Without significant changes

 

 

NDS

 

5.65

0.41

5.62

0.42

5.04

0.41

5.26

0-44

Decrease at 13th day, slow recovery at 30th day

 

 

SD

 

5.48

0.40.

5.88

0.42

5.84

0.42

5.86

0.47

Increment at 10th day

 

 

SDS

 

5.55

0.41

5.84

0.41

5.77

0.43

5.88

0.47

Increase is observed at 30th day

3

Monocytes

ND

 

0.71

0.12

0.74

0.17

0.74

0.16

0.77

0.15

Without significant changes

 

 

NDS

 

0.70

0.13

0.71

0.16

0.56

0.15

0.65

0.16

Decrease level at 13th day, Slow recovery at 30th day

 

 

SD

 

0.71

0.13

    1.  

0.16

0.72

0.15

0.72

0.16

Without significant changes

 

 

SDS

 

0.69

0.15

0.71

0.15

0.70

0.15

0.72

0.15

Without significant changes

4

Eosinophils

ND

 

0.16

0.05

0.16

0.04

0.17

0.04

0.18

0.04

Without significant changes

 

 

NDS

 

0.16

0.04

0.16

0.05

0.12

0.05

0.15

0.05

Decrement at day 13th, Slow recovery at ay 30th.

 

 

SD

 

0.15

0.03

0.18

0.05

0.22

0.04

0.21

0.05

Increment at 10th day

 

 

SDS

 

0.15

0.04

0.18

0.06

0.18

0.04

0.21

0.06

Increment and fast recovery

5

Basophils

ND

 

0,05

0.01

0.06

0.01

0.06

0.01

0.05

0.01

Without significant changes

 

 

NDS

 

0.05

0.02

0.06

0.01

0.01

0.02

0.04

0.01

Decrement at 13th day, Slow recovery at day 30th.

 

 

SD

 

0.05

0.01

0.08

0.02

0.075

0.02

0.076

0.01

Increment at 10th day

 

 

SDS

 

0.05

0.01

0.08

0.01

0.10

0.01

0.08

0.1

Increment at 10th day

Figures 8,9).

Figure 8: Lymphocyte, neutrophil and monocytes coin YPG or YPX media at 28°C and 130 rpm for 24 hours.in BALB/c mice. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group

Figure 8: Lymphocyte, neutrophil and monocytes coin YPG or YPX media at 28°C and 130 rpm for 24 hours.in BALB/c mice. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group

Figure 9: Eosinophil and basophil counts in BALB/c mice. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group.

Figure 9: Eosinophil and basophil counts in BALB/c mice. ND: Control diet, not stressed; NDS: Control diet, stressed; SD: Supplemented diet, not stressed; SDS: Supplemented diet, stressed. N= 5 in each experimental group.

Compared to the control not stressed groups, an alteration from normal values was observed particularly at the end of induced stress period (day 13) in two groups subjected to induced stress, but the group received normal diet without yeast supplement during the previous 10 days is the most affected when the induced stress was suspended. The oxidative stress induced by malnutrition and inadequate environmental living conditions as the change resulted from livestock handling. These changes resulted in metabolic dysfunction, decreased availability of essential nutrients, loss of electrolytes and amino acids, increased metabolic requirements, homeostatic and energy imbalance, physiological dysregulation and overall a poor health condition [56]. The beneficial effect of diet supplementation with yeast rich in β-glucans is obvious when compare the evolution of weight, liver, renal, immunological and antioxidant blood markers. In general metabolic alterations are less severe and animals recover completely and more rapidly when normal environmental conditions were restored. Kanagasabapathy [57], reported positive effects of β-glucans rich extract from Plerotus sajor caju to prevent obesity and oxidative stress in mice fed on high fat diet.

Below is a description of biochemical and immunological tests results including a description of observed evolutionary

 tendency for each measured markers (Table 3,4). Our results are consistent with those obtained by others authors, although some variation in specific values can be observed due the experimental conditions, the characteristics of induced stress and the fact that we analyzed only mice periphery blood [58,59]. The same tendency in analyzed serum indicators has been found in rats and dogs [60,61].

Glucose: Glucose is a key diagnostic marker of energy metabolism and overall metabolic health associated with diabetes mellitus, but also indicative of hyperactivity of thyroid, pituitary or adrenal glands. Hypoglycemia can be associated with insulin secreting tumors, myxedema, hypopituitarism orhypoadrenalism. The balance between oxidative and antioxidant processes appears to be sensitive to glucose levels with moderate elevations of glucose affecting the oxidative

status [62]. Chronic hyperglycemia can induce oxidative stress in organism, by the generation of free radicals, which may increase lipid peroxidation, depletes antioxidants, and enhances oxidative stress in individuals with type 2 diabetes [63]. Drastic Animals change in glucose levels were not observed but feed yeast supplemented diet showed better values compared with the animals fed control diet which showed increased glucose levels at day 13th (post stress) with couldn’t completely return to normal values at day 30th (Table 3). The relationship between glucose fluctuations and oxidative stress markers has a multifactorial character [64].

Total protein: Total protein concentration market showed increased levels at day 13th in stressed animals fed with control diet (post stress) but at day 30th the return to normal values was almost completely, we considered that since all animal were health the organism can assimilate induced stress and values of total protein could return to normality. In animals fed supplemented diet the variations in total protein levels were not significant.

BSA: Albumin plays an important role in the regulation and maintenance of homeostasis due its anti-oxidant and anticoagulant actions. Albumin also functions as a carrier for nutritional factors and drugs, and is an effective plasma pH buffer. Abnormal serum albumin is a good indicator for morbidity and mortality, and may reveal liver disease, nephritic syndrome, malnutrition and protein-losing enteropathies in the context of other plasma markers. High albumin levels can also be associated with dehydration and starvation [65]. Mice exposed to stressinducing conditions showed increased serum albumin level at day 13th. The group fed the probiotic-supplemented diet returned to normal levels at day 30th but animals fed control diet normal BSA levels. But the BSA level were not well correlated with total protein level as we expected, probably increased on BSA level in mice fed control diet and stressed was joined with decreases in other serum proteins.

Urea BUN: Urea is the major end product of protein catabolism in animals. It is the primary vehicle for removal of toxic ammonia from the body. Urea determination is very useful in assess kidney function. In general, increased urea levels are associated with nephritis, renal ischemia, urinary tract obstruction, and certain extra renal diseases, congestive heart failure, liver diseases and diabetes. Decreased levels indicate acute hepatic insufficiency or may result from over-vigorous parenteral fluid therapy. Urea level in animals fed with probiotic supplemented slightly increased at day 13th and return to normal level at day 30th compared with control group fed normal diet and stressed, where urea level increased dramatically and the complete return to normal levels was not completely reached at the 30th day.

Uric acid: Uric Acid is the waste product of purine degradation. Uric acid is an important indicator in diagnose and evaluation of kidney function. The metabolism of purines to uric acid requires the action of xanthine oxido reductase (XOR), a dual-function enzyme that has xanthine oxidase (XO) or xanthine dehydrogenase (XDH) activities. XOR exist as XDH, a NAD+ - dependent dehydrogenase that catalyzes the hydroxylation of hypoxanthine to xanthine and then the hydroxylation of xanthine to uric acid with the production of NADH. Uric acid has a protective antioxidant action at physiological concentrations, whereas in excess it has been associated with conditions such as hypertension and nephrolithiasis. Additionally, uric acid may induce an inflammatory response and oxidative stress when released from injured cells in damaged tissue [66]. In mammals, XDH can be converted into XO under a variety of pathophysiological conditions, such as inflammation, ischemia/ reperfusion injury, or liver damage by viral infection or toxic substances [67]. Both XO and XDH may generate the reactive oxygen species (ROS) superoxide anion (O2 •-) and hydrogen peroxide (H2 O2 ) during the oxidation of substrates. This reaction is inversely dependent on pH and O2 tension and is thus favored under hypoxic conditions. In the reverse reaction, urate has the ability to scavenge oxygen radicals. Therefore hyperuricemia may be responsible for increase in serum antioxidant capacity. Both uric acid and ascorbic acid are strong reducing agents (electron donors) and potent antioxidants. In humans, over half the antioxidant capacity of blood plasma comes from hydrogen urate ion [66]. Current evidences regarding the antioxidant role of uric acid and suggests that it has an important role as an oxidative stress marker and a potential therapeutic role as an antioxidant. Further well designed clinical studies are needed to clarify the potential use of uric acid (or uric acid precursors) in diseases associated with oxidative stress. It has been proposed that UA may represent one of the most important low-molecularmass antioxidants in the human biological fluids. Current evidence suggests uric acid can be an important oxidative stress marker and a potential therapeutic antioxidant Apart from its action as radical scavenger, UA uriate can also chelate metal ions, like such as iron and copper, converting them to poorly reactive forms unable to catalyze free-radical reactions [66-71]. UA level in animals fed with probiotic supplemented slightly increased at day 13th and return to normal level at day 30th compared with control group fed normal diet and stressed, where increased in UA levels to high compared with normal values and the complete return to normal levels was not completely reached at the 30th day.

Creatinine: Creatinine is synthesized in the body at a fairly constant rate. Creatine is generated from creatine-phosphate as a result of muscle contractions. Creatinine is excreted into in the urine. In healthy individuals, creatinine is independent of diet and is fairly constant. The creatinine clearance test is very convenient for measuring and evaluating glomerular filtration rate. In kidney disease plasma creatinine levels become elevated due to reduced creatinine filtration and excretion rate. Our mice feed the control diet had increased creatinine levels at the 13th day (post-stress induction) and had an incomplete recovery at day 30. These results are consistent with previous reports showing impaired kidney function, at least temporary, under oxidative stress conditions [72-73]. The animals fed probiotic supplemented diet showed less increase in creatinine level and completely return to normal level when experiment concluded.

Alanine transaminase: Alanine Transaminase (ALT) allows the conversion of alanine and α-ketoglutarate to pyruvate and glutamate. This enzyme plays a central in process such as gluconeogenesis and amino acid metabolism. ALT is located mainly in the liver, and, and in less quantity in other organ as kidney, heart, muscle, and pancreas tissues. Usually le serum levels of ALT are low, and increased serum ALT activity is widely used as a marker for liver damage. Mice exposed to stress-inducing conditions showed increased serum ALT levels immediately after stress induction at 13th day, animals fed with the probiotic-supplemented diet returned to normal levels at 30th day. Our observations are well correlated with the results obtained by Cicho?-Lach and Michalak [74].

Aspartate transaminase: Aspartate Transaminase (AST), also known as serum glutamic oxaloacetic transaminase (GOT), facilitates the conversion of aspartate and β-ketoglutarate to oxaloacetate and glutamate. AST is a pyridoxal phosphatedependent enzyme that exists in cytoplasmic and mitochondrial forms, GOT1 and GOT2, respectively. AST plays a role in gluconeogenesis, amino acid metabolism and the urea and tricarboxylic acid cycles AST is usually part of test panels for the evaluation of liver function and the diagnosis of conditions such as, myocardial infarction, acute pancreatitis, acute hemolytic anemia, severe burns, acute renal disease and trauma. In our study, similar to ALT results, mice exposed to stress-inducing conditions showed increased serum AST levels immediately after stress induction, but only animals fed the probiotic-supplemented diet recovered completely.

Alkaline phosphatase: Alkaline phosphatase (ALP) drives the hydrolysis of phosphate esters in an alkaline environment. This reaction produces an organic radical and inorganic phosphate. In mammals, this enzyme is found mainly in the liver and bones. Increased serum ALP levels are a good an indicator of impaired liver function and have been associated with conditions such as malignant biliary obstruction, primary biliary cirrhosis, primary sclerosing cholangitis, hepatic lymphoma and sarcoidosis [75,76]. Mice exposed to stress-inducing conditions showed increased serum ALP levels immediately after stress induction at 13th day, but animals fed the probiotic-supplemented diet showed less increase and the normal ALP levels were recovered completely at the 30th day.

Glutathione peroxidase: Glutathione peroxidase (GSH-Px) is a common antioxidant enzyme that functions to scavenge ROS similar to superoxide dismutase and catalase. GSH-Px plays an important role in hemoglobin protection from oxidation. The increasing concentration of reduced glutathione oxidation can affect erythrocyte’s membrane and enzymatic systems, particularly during the glycolysis [76,77]. In our study, GSH-Px activity decreased at day 13th post-stress induction, but returned to normal levels only in mice feed the probiotic-supplemented diet by day 30.

Plasma total antioxidant capacity (TAC): Oxidative stress can be assessed by measuring the concentration and dynamics of endogenous antioxidant compounds. However, these measurements can be somewhat inconsistent due to variations in the nature of ROS produced. Measurement of the total antioxidant capacity (TAC) of bodily fluids is believed to be a more useful indicator of the ability of antioxidants to protect against oxidative stress damage. TAC can determine spectrophotometrically in plasma [61]. Glutathione peroxidase (GSH-Px) is a common antioxidant enzyme that functions to scavenge ROS similar to superoxide dismutase and catalase. GSH-Px plays an important role in hemoglobin protection from oxidation. The increasing concentration of reduced glutathione oxidation can affect erythrocyte’s membrane and enzymatic systems, particularly during the glycolysis [76,80]. In our study, GSH-Px activity decreased at day 13th post-stress induction, but returned to normal levels only in mice feed the probioticsupplemented diet by day 30. Our results showed that mice feed control diet had a lower TAC at day 13 post-stress induction and did not return completely to normal levels by day 30. But the alteration in this parameter is much lower than we have expected. TAC assay is mostly focused on low molecular weight, chain breaking excluding the contribution made by antioxidant enzymes and metal-binding proteins [81].

Immunological status: The immunological status of animals was evaluated by the determining lymphocyte, neutrophil, monocyte, eosinophil, and basophil counts (Table 4, Figures 7- 9). The total leukocyte count decreased in the animal group fed control diet, but not in the same proportion among the different types of leukocyte. Lymphocytes were the most affected cell type, falling 35.3% from 9.97x103 to 6.45 x103 cells/µL between days 10 and 13 post-stress induction. In the groups fed the probioticsupplemented diet, there was an increase in lymphocyte count prior to stress induction (day 10), but the group fed with normal control diet the number of lymphocytes fell and complete recovery of normal values were not observed. A decrease in cell count was also observed for the other cell populations: -10.32% (neutrophils), -21.12% (monocytes), -25% (eosinophils) and -6.6% (basophils) in mice fed control diet. These results suggest that the probiotic-supplemented diet had a stimulatory effect on the proliferation of different leukocyte populations, thus providing better protection against infections [80,81]. Malnutrition always results in an immune deficiency in addition other alteration in living and environmental conditions leading to oxidative stress increase the level of physiological, metabolic and immunological affectations [59]. We hypothesize that β-glucans in the yeast cell wall, which are absent from mammalian cells, play an important role in the overall stimulation of innate and acquired immunity [80- 82].

These results support the idea of systemic positive effect of dietary supplementation with booth selected yeast strains and the possibility to apply selected yeasts as a probiotic in humans and animal. In animal production during handling and manipulation of animals, occur changes in their living condition (change of feeding, transfers to another location, transport to a new region, etc) as well as changes in animal live cycle (birth, breastfeeding or breeding, weaning, calving, etc). These drastic changes in living conditions and stages of the life cycle can have a dramatic impact on the productivity of the livestock by weight loss, slow weight gain, organ physiological malfunction and diminish of immunological defenses [82-85]. We seek to minimize its consequences with dietary supplements as preventive treatment. The protection is probably due to multiple mechanisms involving free radical scavenger properties and increasing the antioxidant status.

CONCLUSION

Oxidative stress induced by dietary restriction and other adverse environmental conditions can lead to adverse health effects such as body weight loss, immunosuppression and altered metabolism. In this study, we demonstrate that diet supplementation with high β-glucan producing yeast as a probiotic can have a positive health impact by reducing or preventing the noxious effects of oxidative stress. Our results support the possible use of one specific yeast strains (Saccharomyces cerevisiae LX36) as a probiotic in humans and animal. During animal production, changes in living conditions due to handling and manipulation (e.g., changes in feeding and housing location, and life cycle changes such as forced mating, delivery, breastfeeding, weaning, calving, etc) could have a dramatic impact on livestock productivity due to weight loss, slow weight recovery, metabolic dysfunction and reduced immunological competence. We seek to minimize the adverse effects of oxidative stress by supplementing animal feed with high β-glucan-producing probiotics as prophylactic treatment.

REFERENCES

1. Suh SO, McHugh JV, Pollock DD, Blackwell M. The beetle gut: a hyperdiverse source of novel yeasts. Mycol Res. 2005; 109: 261-265.

2. Sláviková E, Vadkertiová R. The diversity of yeasts in the agricultural soil. J Basic Microbiol. 2003; 43: 430-436.

3. Barnett JA. The entry of D-ribose into some yeasts of the genus Pichia. J Gen Microbiol. 1975; 90: 1-12.

4. Herrera CM, Pozo MI. Nectar yeasts warm the flowers of a winterblooming plant. Proc Biol Sci. 2010; 277: 1827-1834. 

5. Adams MR, Marteau P. On the safety of lactic acid bacteria from food. Int J Food Microbiol. 1995; 27: 263-264.

6. Alabi AO. The use of probiotics techniques for controlling bacterial diseases in marine invertebrates hatcheries. J Shellfish Res. 2000; 19: 650.

7. Doyon M, Labrecque JA. Functional foods: a conceptual definition. Brit Food J. 2008; 110: 1133-1149.

8. Bigliardi B, Galati F. Innovation trends in the food industry: The case of functional foods. Trends Food Sci Technol. 2013; 31: 118-129.

9. Songisepp E, Kals J, Kullisaar T, Mandar R, Hutt P, Zilmer, et al. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J. 2005; 4: 22.

10. Hoffman CS, Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene. 1987; 57: 267-272.

11. Conrad L. Schoch C, Seifert KA, Huhndorf S, Robert V, Spouge JL, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci. 2012; 109: 6241-6246.

12. Granchi L, Bosco M, Messini A, Vincenzini M. Rapid detection and quantification of yeast species during spontaneous wine fermentation by PCR-RFLP analysis of the rDNA ITS region. J Appl Microbiol. 1999; 87: 949-956.

13. Belloch C, Fernandez-Espinar T, Querol A, Dolores Garcia M, Barrio E. An analysis of inter- and intraspecific genetic variabilities in the Kluyveromyces marxianus group of yeast species for the reconsideration of the K. lactis taxon. Yeast. 2002; 19: 257-268.

14. McCleary BV, Draga A. Measurement of β-Glucan in Mushrooms and Mycelial Products. J AOAC Int. 2016; 99: 364-373.

15. Nikolic M, Lopez P, Strahinic I, Suarez A. Characterization of the exopolysaccharide (EPS)-producing Lactobacillus paraplantarum BGCG11 and its non-EPS producing derivative strains as potential probiotics. Int J Food Microbiol. 2012; 158:155-162

16. Guidelines for Ethical Conduct in the Care and Use of Nonhuman Animals in Research. American Psychological Association (APA) Washington DC, US. 2012.

17. O’Connell KE, Mikkola AM, Stepanek AM, Vernet A, Hall CD, Sun CC, et al. Practical Murine Hematopathology: A Comparative Review and Implications for Research. Comp Med. 2015; 65: 96-113.

18. Carvajal Barriga EJ, Libkind D, Briones AI, UbedaIranzo J, Portero P, Roberts I, et al. Yeasts Biodiversity and Its Significance: Case Studies in Natural and Human-Related Environments, Ex Situ Preservation, Applications and Challenges. Changing Diversity in Changing Environment. 2011.

19. Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol. 2017; 13: 94-162.

20. Koren E, Kohen R, Ginsburg I. Polyphenols enhance scavenging capacities of human blood by binding to red blood cells. ExpBiol Med. 2010; 235: 689-699.

21. Pasquini A, Gavazza A, Biagi G, Lubas G. Oxidative stress in lymphoma: Similarities and differences between dog and human. Comp Clin Pathol. 2015; 24: 69-73.

22. Reyes-Becerril M, Tovar-Ramirez D, Ascencio-Valle F, Civera-Cerecedo R, Gracia-LOpez V, Barbosa-Solomieu V. Effects of dietary live yeast Debaryomyces hansenii on the immune and antioxidant system in juvenile leopard grouper Mycteroperca rosacea exposed to stress. Aquacul. 2008; 280: 39-44.

23. Kricka W, Fitzpatrick J, Bond U. Metabolic engineering of yeasts by heterologous enzyme production for degradation of cellulose and hemicellulose from biomass: a perspective. Front Microbiol. 2014. 22; 5: 174.

24. Prakash G, Varma AJ, Prabhune A, Shouche Y, Rao M. Microbial production of xylitol from D-xylose and sugarcane bagasse hemicellulose using newly isolated thermotolerant yeast Debaryomyces hansenii. Bioresour Technol. 2011; 102: 3304-3308.

25. Las Heras-Vazquez FJ, Mingorance-Cazorla L, Clemente-Jimenez JM, Rodriguez-VicoI F. Identification of yeast species from orange fruit and juice by RFLP and sequence analysis of the 5.8S rRNA gene and the two internal transcribed spacers. FEMS Yeast Res. 2003; 3: 3-9.

26. Doniger SW, Kim HS, Swain D, Corcuera D, Williams M, Yang SP, et al. A catalog of neutral and deleterious polymorphism in yeast. PLoS Genet. 2008; 4: e1000183.

27. Chavan P, Mane S, Kulkarni G, Shaikh S, Ghormade V, Nerkar DP, et al. Natural yeast flora of different varieties of grapes used for wine making in India. Food Microbiol. 2009; 26: 801-808.

28. Bai M, Qing M, Guo Z, Zhang Y, Chen X, Bao Q , et al. Occurrence and dominance of yeast species in naturally fermented milk from the Tibetan Plateau of China. Can J Microbiol. 2010; 56: 707-714.

29. Carvalho CM, Meirinho S, Estevinho ML, Choupina A. Yeast species associated with honey: different identification methods. Archives Zootechnol. 2010; 59: 103-113.

30. Hakim AS, Abuelnaga, AS, Sayed El Ahl. Isolation, biochemical identification and molecular detection of yeasts from Kareish cheese. Inter J Microbiol Res. 2013; 4: 95-100.

31. Cadete RM, Melo MA, Dussanm KJ, Rodrigues R, Silva SS, Zilli JE, et al. Diversity and Physiological Characterization of D-Xylose-Fermenting Yeasts Isolated from the Brazilian Amazonian Forest. Plos one. 2012; 7: e43135.

32. Arangao L, Gomes EA, Mendoca-Hagler L, Hagler AN. Yeast communities associated with sugarcane in Campos, Rio de Janeiro, Brazil. Int Microbiol. 1998; 1: 205-208.

33. Wójcik M, Kordowska-Wiater M. The occurrence of killer activity in yeasts isolated from natural habitats. Acta Biochim Pol. 2015; 62: 821- 824.

34. Nasir A, Rahman SS, Hossain MM, Choudhury N. Isolation of Saccharomyces cerevisiae from pineapple and orange and study of metal’s effectiveness on ethanol production. Eur J Microbiol Immunol. 2017; 7: 76-91.

35. Starmer WT, Lachance MA. Yeast Ecology. In: Kurtzman CP, Fell JW, Boekhout T, editors. The Yeasts A Taxonomic Study. 5th edn. Elseiver. 2011; 65-86.

36. Wiens F, Zitzmann A, Lachance MA, Yegles M, Pragst F, Wurst FM , et al. Chronic intake of fermented floral nectar by wild treeshrews. Proc Natl Acad Sci. 2008;105:10426-10431.

37. Russo G, Libkind D, Ulloa RJ, de Garcia V, Sampaio JP, van Broock MR. Cryptococcus agrionensis sp. nov., a basidiomycetous yeast of the acidic rock drainage ecoclade, isolated from an acidic aquatic environment of volcanic origin. Int J Syst Evol Microbiol. 2010; 60: 996-1000.

38. Nagahama T. Yeast Biodiversity in Freshwater, Marine and DeepSea Environments. In: Peter G, Rosa C, editors. Biodiversity and Ecophysiology of Yeasts. Berlin: Springer. 2006; 241-162.

39. Gaggìa F, Mattarelli P, Biavati B. Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol. 2010; 1: 15-28.

40. Buyuksirit T, Kuleasan H. Antimicrobial Agents produced by Yeast. Int J Nutr Food Eng. 2014; 8: 1114-1117.

41. Chanchaichaovivat A, Ruenwongsa P, Panijpan B. Screening and identification of yeast from fruits and vegetables: Potential for biological control of postharvest chilli anthracnose (Colletotrichumcapsici). Biol Cont. 2007; 42: 326-335.

42. Breuer U, Harms H. Debaryomyces hansenii--an extremophilic yeast with biotechnological potential. Yeast. 2006; 23: 415-437.

43. Butinar L, Santos S, Spencer-Martins I, Oren A, Gunde-Cimerman N. Yeast diversity in hypersaline habitats. FEMS Microbiol Lett. 2005; 244: 229-234.

44. Nakase T, Suzuki M, Phaff HJ, Kurtzman CP. Debaryomyces. Lodder & Kreger-vanRij Nom. Cons. In: Kurtzman CP, Fell JW, editors. The Yeasts-a Taxonomic Study. Amsterdam: Elsevier. 1998; 157-173.

45. Zanello G, Meurens F, Berri M, Salmon H. Saccharomyces boulardii effects on gastrointestinal diseases. Curr Issues Mol Biol. 2009; 11: 47-58.

46. O’Neil CE, Keast DR, Fulgoni VL, Nicklas TA. Food sources of energy and nutrients among adults in the US: NHANES 2003–2006. Nutrients. 2012; 4: 2097-2120.

47. Ohashi Y, Ushida K. Health-beneficial effects of probiotics: Its mode of action. Anim Sci J. 2009; 80: 361-71.

48. McMeekin TA, Brown J, Krist K, Miles D, Neumeyer K, Nichols DS , et al. Quantitative microbiology: a basis for food safety. Emerg Infect Dis. 1997; 3: 541-549.

49. Van Mulders SE, Christianen E, Saerens SM, Daenen L, Verbelen PJ, Willaert R, et al. Phenotypic diversity of Flo protein family-mediated adhesion in Saccharomyces cerevisiae. FEMS Yeast Res. 2009; 9: 178- 190.

50. Verstrepen KJ, Klis FM. Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol. 2006; 60: 5-15.

51. Verstrepen KJ, Reynolds TB, Fink GR. Origins of variation in the fungal cell surface. Nat Rev Microbiol. 2004; 2: 533-540.

52. Verstrepen KJ, Jansen A, Lewitter F, Fink GR. Intragenic tandem repeats generate functional variability. Nat Genet. 2005; 37: 986-990.

53. Zupancic ML, Frieman M, Smith D, Alvarez RA, Cummings RD, Cormack BP. Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol Microbiol. 2008; 68: 547-559.

54. Kovachev SM, Vatcheva-Dobrevska RS. Local Probiotic Therapy for Vaginal Candida albicans Infections. Probiotics Antimicrob Proteins. 2015; 7: 38-44.

55. Sabbatini S, Monari C, Ballet N, Mosci P, Decherf AC, Pelerin F, et al. Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis. Virulence. 2018; 9: 954-966.

56. Villafuerte G, Miguel-Puga A, Murillo E, Machado S, Manjarrez E, AriasCarrion O. Sleep Deprivation and Oxidative Stress in Animal Models: A Systematic Review. Oxid Med Cell Longev. 2015; 2015: 1-15.

57. Kanagasabapathy G, malek SN, Mahmood A, Chua K, Vikineswary S, Kuppusamy U. Beta-rich extract from Plerotus sajor-caju (Fr) singer prevents obesity and oxidative stress in mice fed on high-fat diet. Evid Based Complement Alternat Med. 2013; 1-10.

58. Santos EW, Oliveira DC, Hastreiter A, Batista da Silva G, Beltrn SJ, Tsujita M, et al. Hematological and biochemical reference values for C57BL/6,Swiss Webster and BALB/c mice Braz. J Vet Res Anim Sci. 2016; 53: 138-145.

59. Morris HJ, Carrillo OV, Llaurado G, Alonso ME, Bermudez RC, LebequeY, et al. Effect of starvation and refeeding on biochemical and immunological status of Balb/c mice: an experimental model of malnutrition. Immunopharmacol Immunotoxicol. 2011; 33: 438-446.

60. Ohta Y, Kaida S, Chiba S, Tada M, Imai M, Kawanishi M. Involvement of Oxidative Stress in Increases in the Serum Levels of Various Enzymes in Rats with Water Immersion Restraint Stress. J Clin Biochem Nutr. 2009; 45: 347-354.

61. Kendall A, Woolcock A, Brooks A, Moore GE. Glutathione Peroxidase Activity, Plasma Total Antioxidant Capacity and Urinary F2- Isoprostanes as Markers of Oxidative Stress in Anemic Dogs. J Vet Intern Med. 2017; 31: 1700-1707.

62. Menon V, Ram M, Dorn J, Armstrong D, Muti P, Freudenheim JL , et al. Oxidative stress and glucose levels in a population-based sample. Diabet Med. 2004; 21: 1346-1352.

63. Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci. 2008; 65: 71-74.

64. Altincik A, Tuglu B, Demir K, Catli G, Abaci A, Bober E. Relationship between oxidative stress and blood glucose fluctuations evaluated with daily glucose monitoring in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2016; 29: 435-439.

65. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, et al. Antioxidant status in patients with uncomplicated insulindependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1997; 27: 484-490.

66. Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C , et al. Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med. 2016; 29: 3-8.

67. Battelli MG, Bolognesi A, Polito L. Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme. Biochim Biophys Acta. 2014; 1842: 1502-1517.

68. Halliwell B, Gutteridge JMC. Antioxidant protection by low molecularmass agents: compounds synthesized in vivo. In: Halliwell B, Gutteridge JMC, editors. Free Radicals in Biology and Medicine. UK: Oxford University Press. 1999; 195-197.

69. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acidiron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986; 235: 747-754.

70. Einsele H, Clemens MR, Wegner U, Waller HD. Effect of free radical scavengers and metal ion chelators on hydrogen peroxide and phenylhydrazine induced red blood cell lipid peroxidation. Free Radic Res Commun. 1987; 3: 257-263.

71. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric Acid and Oxidative Stress. Curr Pharm Des. 2005; 11: 4145-4151.

72. Ly JP, Onay T, Quaggin E. Mouse models to study kidney development, function and disease. Curr Opin Nephrol Hypertens. 2011; 20: 382- 390.

73. O’Connell KE, Mikkola AM, Stepanek AM, Vernet A, Hall C, Sun CC, et al. Practical Murine Hematopathology: A Comparative Review and Implications for Research. Comp Med. 2015; 65: 96-113.

74. Cicho?-Lach H, Michalak A. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 2014; 20: 8082-8091.

75. Jin Y, Wang J, Pan X, Wang L, Fu Z. Cis-Bifenthrin enantioselectively induces hepatic oxidative stress in mice. Pestic Biochem Physiol. 2013; 107: 61-67.

76. Edwards CJ, Fuller J. Oxidative stress in erythrocytes. Comp Haematol Int. 1996; 6: 24-31.

77. Fibach E, Dana M. Oxidative stress in paroxysmal nocturnal hemoglobinuria and other conditions of complement-mediated hemolysis. Free Radic Bio Med. 2015; 88: 63-69.

78. Young IS. Measurement of total antioxidant capacity. J Clin Pathol. 2001; 54: 339. 79.Ritz BW, Gardner EM. Malnutrition and energy restriction differentially affect viral immunity. J Nutr. 2006; 136: 1141-1144.

80. Matarese G, La Cava A. The intricate interface between immune system and metabolism. Trends Immunol. 2004; 25: 193-200.

81. Schaible UE, Kaufmann SH. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007; 4: e115.

82. Furukawa K, Yamamori H, Takegi K, Hayashi N, Suzuki R, Kakajima N, et al. Influence of soybean emulsion on stress response and cell mediated immune function in moderately or severe stressed patients. Nutrition 2002; 18: 235-240.

83. Latgé JP. Tasting the fungal cell wall. Cell Microbiol. 2010; 12: 863- 872.

84. Barreto-Bergter E, Figueiredo RT. Fungal glycans and the innate immune recognition. Front Cell Infect Microbiol. 2014; 1: 1-17.

85. Sonck E, Devriendt B, Goddeeris B, Cox E. Varying effects of different β-glucans on the maturation of porcine monocyte-derived dendritic cells. Clin Vaccine Immunol. 2011; 18: 1441-1446.

de Jesus Torres-Osorno A, López-Mendoza FJ, de la Riva GA (2018) Isolation and Characterization of Wild Yeast Strains Producing Beta Glucans; Probiotic Systemic Effect in Mice under Conditions of Environmental Stress. Ann Food Process Preserv 3(1): 1023.

Received : 24 Aug 2018
Accepted : 21 Sep 2018
Published : 23 Sep 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X